GlassScriptPhysician profile
Bryan T Hyland
NPI 1215972591
$5,878.54
in general payments reported to CMS, 2019-2025
46 companies · $921 in 2025
The $921 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2020: $568 · 2021: $736 · 2022: $1,304 · 2023: $1,046 · 2024: $845 · 2025: $921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,713 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,712.54 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $905.01 | 2019-2025 | Airsupra, Farxiga |
| Abbvie INC. | $781.23 | 2021-2024 | |
| Astellas Pharma US INC | $498.17 | 2022-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $417.88 | 2021-2025 | |
| Novo Nordisk INC | $381.37 | 2020-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $327.16 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $269.21 | 2019-2022 | |
| Exact Sciences Corporation | $192.26 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $192.15 | 2023-2025 | Rexulti, Vyepti |
| Glaxosmithkline, LLC. | $178.09 | 2021-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Kowa Pharmaceuticals America, INC. | $136.09 | 2022-2025 | Zoryve |
| Phathom Pharmaceuticals, INC. | $135.34 | 2024-2025 | Voquezna |
| Nevro Corp. | $128.15 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $106.60 | 2022 | |
| Amarin Pharma, INC. | $101.07 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Hyland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.